UCHL3 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-UCHL3 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityUCHL3
Clonemonoclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size0.03 mg, 0.1 mg, 0.1 mg
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionDeubiquitinating enzyme (DUB) that controls levels of cellular ubiquitin through processing of ubiquitin precursors and ubiquitinated proteins. Thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of either ubiquitin or NEDD8. Has a 10-fold preference for Arg and Lys at position P3, and exhibits a preference towards 'Lys-48'-linked Ubiquitin chains. Deubiquitinates ENAC in apical compartments, thereby regulating apical membrane recycling. Indirectly increases the phosphorylation of IGFIR, AKT and FOXO1 and promotes insulin- signaling and insulin-induced adipogenesis. Required for stress- response retinal, skeletal muscle and germ cell maintenance. May be involved in working memory. Can hydrolyze UBB(+1), a
ImmunogenImmunogen: A synthesized peptide derived from human UCHL3 Subcellular Localization: Cytoplasm. Tissue Specificity: Highly expressed in heart, skeletal muscle, and testis.
Other Names[Ubiquitin carboxyl-terminal hydrolase isozyme L3; UCH-L3; 3.4.19.12; Ubiquitin thioesterase L3; UCHL3]
Gene, Accession #[UCHL3], Gene ID: 7347, NCBI: NP_001257881.1, UniProt: P15374
Catalog #MBS1750033
Price$160, $340, $340
Order / More InfoUCHL3 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.